Replies to post #13553 on GTC Biotherapeutics (fka GTCB)

[croumagnon]

Interesting table. Based on that, and assuming that any takeover will have management's blessings, I would surmise that any takeover will be at a premium no less that $1.5, and probably in the neighborhood of $2...

[rkcrules2001]

Executive Options

These seem pretty inconsequential vis a vis a buy out, certainly for one at or below $2.

Even at $2 Cox would only make about $280k on the options before taxes. Only about 6 months average compensation.

Maybe he'd get more excited about what a buyout would do for the 1MM or so shares he owns outright. But my guess is he'd just as soon stay at the trough, feeding on his tasty $600k+ annual compensation.